Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients

BACKGROUND: Minor protease inhibitor (PI) mutations often exist as polymorphisms in HIV-1 sequences from treatment-naïve patients. Previous studies showed that their presence impairs the antiretroviral treatment (ART) response. Evaluating these findings in a larger cohort is essential. METHODS: To s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Scherrer, Alexandra U., Ledergerber, Bruno, von Wyl, Viktor, Böni, Jürg, Yerly, Sabine, Klimkait, Thomas, Cellerai, Cristina, Furrer, Hansjakob, Calmy, Alexandra, Cavassini, Matthias, Elzi, Luigia, Vernazza, Pietro L., Bernasconi, Enos, Günthard, Huldrych F.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2012
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3377720/
https://ncbi.nlm.nih.gov/pubmed/22719859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037983
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items